3.74
price up icon0.00%   0.00
pre-market  시장 영업 전:  3.81   0.07   +1.87%
loading
전일 마감가:
$3.74
열려 있는:
$3.77
하루 거래량:
1.08M
Relative Volume:
0.67
시가총액:
$517.18M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-10.69
EPS:
-0.35
순현금흐름:
$-42.28M
1주 성능:
-9.00%
1개월 성능:
+1.08%
6개월 성능:
+97.88%
1년 성능:
+120.00%
1일 변동 폭
Value
$3.65
$3.95
1주일 범위
Value
$3.63
$4.265
52주 변동 폭
Value
$1.27
$4.86

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
명칭
Compass Therapeutics Inc
Name
전화
617-500-8099
Name
주소
80 GUEST STREET, BOSTON
Name
직원
35
Name
트위터
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
CMPX's Discussions on Twitter

CMPX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CMPX
Compass Therapeutics Inc
3.74 641.68M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-01 재개 Raymond James Outperform
2025-04-02 업그레이드 Leerink Partners Market Perform → Outperform
2025-02-24 개시 Guggenheim Buy
2025-02-19 개시 Piper Sandler Overweight
2024-12-23 개시 D. Boral Capital Buy
2024-11-15 다운그레이드 Leerink Partners Outperform → Market Perform
2024-09-16 업그레이드 Ladenburg Thalmann Neutral → Buy
2023-01-31 개시 Jefferies Buy
2023-01-27 개시 Stifel Buy
2022-05-23 재개 H.C. Wainwright Buy
2022-03-15 개시 Ladenburg Thalmann Buy
2022-01-19 개시 B. Riley Securities Buy
2021-12-22 개시 Raymond James Outperform
2021-12-20 개시 SVB Leerink Outperform
2021-12-15 개시 Wedbush Outperform
모두보기

Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스

pulisher
02:39 AM

Will Compass Therapeutics Inc. stock outperform growth indexesJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com

02:39 AM
pulisher
Nov 03, 2025

How to interpret RSI for Compass Therapeutics Inc. stockTrend Reversal & Verified Trade Idea Suggestions - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Compass Therapeutics Inc. recover in the next quarterJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Compass Therapeutics to Participate in Upcoming November Investor Events - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

How Compass Therapeutics Inc. stock performs in weak economyJuly 2025 Fed Impact & Community Shared Stock Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Institutional investors in Compass Therapeutics, Inc. (NASDAQ:CMPX) lost 9.0% last week but have reaped the benefits of longer-term growth - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

Why Compass Therapeutics Inc. stock is seen as undervaluedQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Compass Therapeutics Inc. stock performs in stagflationTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Compass Therapeutics Inc. stock recession proof2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Compass Therapeutics Inc. stock split attract more investorsMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

How Compass Therapeutics Inc. stock trades before earningsJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) - Insider Monkey

Oct 30, 2025
pulisher
Oct 29, 2025

14 Stocks Under $5 with Highest Upside Potential - Insider Monkey

Oct 29, 2025
pulisher
Oct 28, 2025

How to track smart money flows in Compass Therapeutics Inc.Quarterly Investment Review & Weekly High Potential Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Compass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025

Compass Therapeutics Inc (CMPX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
자본화:     |  볼륨(24시간):